Modulation of the Clonal Burden in Patients with Lower-Risk Myelodysplastic Neoplasms Treated with Imetelstat
Stemcell science news,
The first-in-class, direct, competitive telomerase inhibitor, imetelstat, demonstrated higher rates of red blood cell (RBC…